Subcellular Compartmentalization of E2F Family Members is Required for Maintenance of the Postmitotic State in Terminally Differentiated Muscle

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 2000 Mar 22

PMID 10725332

Citations 14

Authors

R M Gill

P A Hamel

Affiliations

Soon will be listed here.

Abstract

Maintenance of cells in a quiescent state after terminal differentiation occurs through a number of mechanisms that regulate the activity of the E2F family of transcription factors. We report here that changes in the subcellular compartmentalization of the E2F family proteins are required to prevent nuclei in terminally differentiated skeletal muscle from reentering S phase. In terminally differentiated L6 myotubes, E2F-1, E2F-3, and E2F-5 were primarily cytoplasmic, E2F-2 was nuclear, whereas E2F-4 became partitioned between both compartments. In these same cells, pRB family members, pRB, p107, and p130 were also nuclear. This compartmentalization of the E2F-1 and E2F-4 in differentiated muscle cells grown in vitro reflected their observed subcellular location in situ. We determined further that exogenous E2F-1 or E2F-4 expressed in myotubes at levels fourfold greater than endogenous proteins compartmentalized identically to their endogenous counterparts. Only when overexpressed at higher levels was inappropriate subcellular location for these proteins observed. At these levels, induction of the E2F-regulated genes, cyclins A and E, and suppression of factors associated with myogenesis, myogenin, and p21(Cip1) was observed. Only at these levels of E2F expression did nuclei in these terminally differentiated cells enter S phase. These data demonstrate that regulation of the subcellular compartmentalization of E2F-family members is required to maintain nuclei in a quiescent state in terminally differentiated cells.

Citing Articles

E2F4DN Transgenic Mice: A Tool for the Evaluation of E2F4 as a Therapeutic Target in Neuropathology and Brain Aging.

Ramon-Landreau M, Sanchez-Puelles C, Lopez-Sanchez N, Lozano-Urena A, Llabres-Mas A, Frade J Int J Mol Sci. 2022; 23(20).

PMID: 36292945 PMC: 9603043. DOI: 10.3390/ijms232012093.

E2F4 transcription factor is a prognostic biomarker related to immune infiltration of head and neck squamous cell carcinoma.

Qi L, Ren Z, Li W Sci Rep. 2022; 12(1):12132.

PMID: 35840663 PMC: 9287548. DOI: 10.1038/s41598-022-16541-4.

A non canonical subtilase attenuates the transcriptional activation of defence responses in .

Serrano I, Buscaill P, Audran C, Pouzet C, Jauneau A, Rivas S Elife. 2016; 5.

PMID: 27685353 PMC: 5074803. DOI: 10.7554/eLife.19755.

Diabetes mellitus--advances and challenges in human β-cell proliferation.

Wang P, Fiaschi-Taesch N, Vasavada R, Scott D, Garcia-Ocana A, Stewart A Nat Rev Endocrinol. 2015; 11(4):201-12.

PMID: 25687999 DOI: 10.1038/nrendo.2015.9.

Targeted gene mutation of E2F1 evokes age-dependent synaptic disruption and behavioral deficits.

Ting J, Marks D, Schleidt S, Wu J, Zyskind J, Lindl K J Neurochem. 2014; 129(5):850-63.

PMID: 24460902 PMC: 4028376. DOI: 10.1111/jnc.12655.

References

Shivji M, La Thangue N . Multicomponent differentiation-regulated transcription factors in F9 embryonal carcinoma stem cells. Mol Cell Biol. 1991; 11(3):1686-95. PMC: 369472. DOI: 10.1128/mcb.11.3.1686-1695.1991. View

Chellappan S, Hiebert S, Mudryj M, Horowitz J, Nevins J . The E2F transcription factor is a cellular target for the RB protein. Cell. 1991; 65(6):1053-61. DOI: 10.1016/0092-8674(91)90557-f. View

Bandara L, La Thangue N . Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature. 1991; 351(6326):494-7. DOI: 10.1038/351494a0. View

Mudryj M, Devoto S, Hiebert S, Hunter T, Pines J, Nevins J . Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell. 1991; 65(7):1243-53. DOI: 10.1016/0092-8674(91)90019-u. View

Huang P, Jones R, Haskell K, Vuocolo G, Hanobik M, Huber H . Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature. 1991; 352(6332):251-4. DOI: 10.1038/352251a0. View

Ewen M, Xing Y, Lawrence J, Livingston D . Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell. 1991; 66(6):1155-64. DOI: 10.1016/0092-8674(91)90038-z. View

Cao L, Faha B, Dembski M, Tsai L, Harlow E, Dyson N . Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature. 1992; 355(6356):176-9. DOI: 10.1038/355176a0. View

Hiebert S, Chellappan S, Horowitz J, Nevins J . The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 1992; 6(2):177-85. DOI: 10.1101/gad.6.2.177. View

Braun T, Bober E, Arnold H . Inhibition of muscle differentiation by the adenovirus E1a protein: repression of the transcriptional activating function of the HLH protein Myf-5. Genes Dev. 1992; 6(5):888-902. DOI: 10.1101/gad.6.5.888. View

10.

Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992; 89(12):5547-51. PMC: 49329. DOI: 10.1073/pnas.89.12.5547. View

11.

Chittenden T, Livingston D, Kaelin Jr W . RB associates with an E2F-like, sequence-specific DNA-binding protein. Cold Spring Harb Symp Quant Biol. 1991; 56:187-95. DOI: 10.1101/sqb.1991.056.01.024. View

12.

Hamel P, Gill R, Phillips R, Gallie B . Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol. 1992; 12(8):3431-8. PMC: 364592. DOI: 10.1128/mcb.12.8.3431-3438.1992. View

13.

Helin K, Lees J, Vidal M, Dyson N, Harlow E, Fattaey A . A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell. 1992; 70(2):337-50. DOI: 10.1016/0092-8674(92)90107-n. View

14.

Kaelin Jr W, Krek W, Sellers W, DeCaprio J, Ajchenbaum F, Fuchs C . Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell. 1992; 70(2):351-64. DOI: 10.1016/0092-8674(92)90108-o. View

15.

Wang J, Helin K, Jin P, Nadal-Ginard B . Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1. Cell Growth Differ. 1995; 6(10):1299-306. View

16.

Guy C, Zhou W, Kaufman S, ROBINSON M . E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol Cell Biol. 1996; 16(2):685-93. PMC: 231048. DOI: 10.1128/MCB.16.2.685. View

17.

Fridell R, Fischer U, Luhrmann R, Meyer B, Meinkoth J, Malim M . Amphibian transcription factor IIIA proteins contain a sequence element functionally equivalent to the nuclear export signal of human immunodeficiency virus type 1 Rev. Proc Natl Acad Sci U S A. 1996; 93(7):2936-40. PMC: 39738. DOI: 10.1073/pnas.93.7.2936. View

18.

LeCouter J, Whyte P, Rudnicki M . Cloning and expression of the Rb-related mouse p130 mRNA. Oncogene. 1996; 12(7):1433-40. View

19.

Xiao Z, Ginsberg D, Ewen M, Livingston D . Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. Proc Natl Acad Sci U S A. 1996; 93(10):4633-7. PMC: 39330. DOI: 10.1073/pnas.93.10.4633. View

20.

Field S, Tsai F, Kuo F, Zubiaga A, Kaelin Jr W, Livingston D . E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell. 1996; 85(4):549-61. DOI: 10.1016/s0092-8674(00)81255-6. View